WASHINGTON -- The U.S. Army will hold a press briefing to discuss their effort in supporting the whole of government approach to investigate and develop vaccine candidates against COVID-19 at 2:30 p.m., Thursday, March 5, in the Pentagon Briefing Room (2D972).The briefing will focus on support measures the U.S. Army Medical Research and Development Command is undertaking.  These measures include coordinating the development of a readily available vaccine, establishing a baseline understanding of current needs, integrating with DoD and interagency partners to identify opportunities and avoid duplication of effort, and continuing to maintain a rapid-response capability for emerging infectious diseases.Speakers will include:- Brig. Gen. Michael J. Talley, commander of USAMRDC and Fort Detrick- Col. Wendy Sammons-Jackson, director of USAMRDC's Military Infectious Diseases Research Program- Dr. Nelson Michael, director, Center for Infectious Disease Research, Walter Reed Army Institute of Research- Dr. Kayvon Modjarrad, director of Emerging Infectious Diseases at the Walter Reed Army Institute of ResearchJournalists interested in attending must RSVP no later than 10 a.m. to usarmy.pentagon.hqda-ocpa.mbx.mrd-press-desk@mail.mil.Please be seated in the Pentagon Briefing Room no later than 2:15 p.m.###